StockSelector.com
  Research, Select, & Monitor Wednesday, May 23, 2018 1:07:44 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Onconova Therapeutics, Inc.$0.37   

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Onconova Therapeutics, Inc. has an overall rank of 6947 out of 7108 stocks based on 4 positive rankings and 7 negative rankings.

Positive Rankings
Target Prices
The average analysts' target price is $7.50 for Onconova Therapeutics using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Onconova Therapeutics is ranked 2.
Oversold RSI
The 14 Day Relative-Strength Index for Onconova Therapeutics is 23.5. An RSI below 30 indicates the stock is oversold. Among companies with a low RSI, Onconova Therapeutics is ranked 37.
Low/Rising MACD
The MACD remains negative, but is rising... suggesting a possible near-term correction. Of companies with a negative, but rising MACD, Onconova Therapeutics is ranked 587.
Up EPS Surprise
Onconova Therapeutics beat the consensus earnings estimate when it last reported quarterly earnings.
Negative Rankings
Negative Revenue Growth
Onconova Therapeutics rank is 11
Negative Cash Growth
Onconova Therapeutics rank is 33
90 Day Loss
Onconova Therapeutics rank is 37
Negative ROA
Onconova Therapeutics rank is 65
Negative Net Margin
Onconova Therapeutics rank is 101
Down EPS Surprise
Onconova Therapeutics missed the consensus earnings estimate when it last reported quarterly earnings.
Price-to-Sales
Onconova Therapeutics rank is 1135







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.